概述
Orbital rhabdomyosarcoma is a rare but aggressive soft tissue sarcoma that affects the orbit (eye socket), primarily in children under 10 years old. It arises from immature skeletal muscle cells and is the most common primary orbital malignancy in children.
症状
- Rapid-onset eye bulging (proptosis)
- Eyelid swelling or discoloration
- Eye movement restriction or misalignment
- Pain or tenderness around the eye
- Vision changes (in later stages)
病因与风险因素
- Exact cause unknown (sporadic in most cases)
- Rare association with genetic syndromes (e.g., Li-Fraumeni, NF1)
- Slight male predominance
- Mostly affects children under age 10
诊断方法
- Urgent ophthalmic and pediatric evaluation
- Orbital imaging (MRI or CT scan)
- Biopsy for histological confirmation and subtype classification
- Metastatic workup (bone marrow, lumbar puncture, PET scan)
治疗方案
- Systemic chemotherapy (standard initial treatment)
- Radiation therapy to preserve eye and control tumor
- Surgery is often limited due to location, but may be used for biopsy or debulking
- Targeted therapy in clinical trial settings
预后情况
- Favorable if diagnosed early and treated promptly
- 5-year survival rate: 80–90% for localized orbital RMS
- Prognosis depends on tumor size, spread, and histologic subtype (embryonal vs. alveolar)
与此类癌症共处
- Regular imaging and oncology follow-up for recurrence monitoring
- Functional and cosmetic rehabilitation (prosthesis or eyelid correction)
- Psychosocial support for child and family
- Monitoring for late effects of treatment (growth, vision, development)
预防与筛查
- No known preventive measures
- Early evaluation of unexplained proptosis in children is essential
- Genetic counseling for families with syndromic risk
FAQs
Q: Can orbital rhabdomyosarcoma be cured?
A：Yes, especially when treated early with a combination of chemotherapy and radiation.
Q: Will my child lose vision?
A：Not necessarily—modern treatments aim to preserve both vision and the eye.
Q: Is this cancer hereditary?
A：Most cases are not, but genetic counseling may be considered in rare familial syndromes.
相关资源
- American Childhood Cancer Organization (ACCO)
- Children’s Oncology Group
- ClinicalTrials.gov
